Altria Group, Inc.

Altria Group, Inc.

MO

$78.08

Updated: 04/11/2026, 18:29:18

Market Cap
$129.86B
Sector
Consumer Defensive
Industry
Tobacco
Country
US

No historical data available

Company Profile

Operating across the United States through its subsidiaries, Altria Group, Inc. is a prominent manufacturer and marketer of both combustible and oral tobacco items. Its portfolio features cigarettes, primarily under the iconic Marlboro brand, alongside cigars and pipe tobacco mainly offered as Black & Mild. The enterprise further provides an assortment of moist smokeless tobacco products, including Copenhagen, Skoal, Red Seal, and Husky, in addition to its on! brand of oral nicotine pouches. Altria distributes its merchandise chiefly to wholesale partners, such as independent distributors, and directly to substantial retail organizations, including major chain stores. The corporation, founded in 1822, maintains its principal offices in Richmond, Virginia.

USD
NYSE
CEO: Salvatore Mancuso
Employees: 5,900
https://www.altria.com
Asset Summaries
Latest generated summaries for MO

No summaries found.

Detailed business
Evidence-backed facts extracted from the latest official annual filing.
MO-10-k-fy2025.html3.3 MBtext/htmlENFiled 25/02/2026Period ended 31/12/2025

Business monitoring

Reported and calculated KPIs plus operational exposure disclosed in the FY 2025 filing.

Evidence-backed · 66 KPI observations

Revenue

$23.3B

FY 2025 · Reported

Net income

$6.9B

FY 2025 · Reported

Gross margin

76.0%

FY 2025 · Calculated

Free cash flow

$9.1B

FY 2025 · Calculated

R&D intensity

0.8%

FY 2025 · Calculated

Share repurchases

$1.0B

FY 2025 · Reported

Earnings and cash generation
USD billions, directly sourced from inline XBRL; free cash flow is operating cash flow less capex.
Profitability and reinvestment
Margins and R&D as a percentage of revenue.
Top products and services
Products and services mentioned in the filing; a quantitative sales breakdown was not disclosed.

Other offerings mentioned without separate sales

Cigarettes (PM USA)
Oral tobacco products (USSTC/Helix)
E-vapor products (NJOY)
Horizon heated tobacco joint venture
Machine-made large cigars (Middleton)

Area-level product sales are displayed only when the filing reports a product × geography breakdown. Regional totals are not allocated across products by estimation.

Geographic footprint
What the filing identifies, separated by location role so partner manufacturing is not presented as Apple-owned factories.
1 named headquarters
0 manufacturing countries
0 individually named factories

Map layer

Pins show disclosed operations. The heatmap colors the filing’s reported geographies; regional figures shade the region and are not estimates for each country.

No reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosure
Named headquarters Manufacturing partner country

Only locations and quantities explicitly supported by the filing are displayed. A country-level manufacturing percentage or product allocation is shown only when the source discloses it; materiality scores are never presented as production shares.

How the business makes money

Wholly owned subsidiaries and business scope

Wholly owned subsidiaries PM USA, Middleton, USSTC, Helix, NJOY, AGDC, ALCS; primarily US operations with substantially all domestic revenue

99%
Source evidence
“We operate primarily within the United States and generate substantially all of our revenue from domestic customers.”

Company overview

Leading U.S. tobacco portfolio for consumers age 21+; Moving Beyond Smoking via smoke-free products and new growth areas

98%
Source evidence
“We have a leading portfolio of tobacco products for U.S. tobacco consumers age 21+. We are Moving Beyond SmokingTM, by responsibly transitioning adult smokers to a smoke-free future”

Altria business overview

U.S.-focused tobacco company; substantially all revenue from domestic customers

98%
Source evidence
“We operate primarily within the United States and generate substantially all of our revenue from domestic customers.”

Holding company liquidity structure

Holding company with $4.5B cash at Dec 31, 2025, reliant on subsidiary dividends; sufficient liquidity for next 12 months

98%
Source evidence
“We are a holding company that is primarily dependent on the capital resources of our subsidiaries to satisfy our liquidity requirements.”

Reportable segments

Smokeable products; oral tobacco products; e-vapor products; all other (Horizon, Helix International, R&D)

98%
Source evidence
“At December 31, 2025, our reportable segments were smokeable products, oral tobacco products and e-vapor products.”

Horizon heated tobacco joint venture with JTI

75%-owned Horizon JV with JTIUH for US heated tobacco stick commercialization; no products in US market at year-end 2025

98%
Source evidence
“At December 31, 2025, we owned a 75% economic interest in Horizon Innovations LLC ("Horizon"), a joint venture with JTI (US) Holding, Inc.”

Operating subsidiaries and brands

Combustibles: PM USA (most profitable U.S. cigarette maker), Middleton (cigars); Smoke-free: USSTC (leading global MST), Helix, NJOY, Horizon JV (HTS); brands Marlboro, Black & Mild, Copenhagen, Skoal, on!, NJOY

97%
Source evidence
“In combustibles, we own PM USA, the most profitable U.S. cigarette manufacturer, and Middleton, a leading U.S. cigar manufacturer.”

Distribution channels

Sales principally to wholesalers/distributors and large retail chain organizations

95%
Source evidence
“Our tobacco subsidiaries sell their tobacco products principally to wholesalers (including distributors) and large retail organizations, including chain stores.”

Cigarettes (PM USA)

PM USA largest U.S. cigarette maker; Marlboro largest-selling brand 50+ years; 61.8 billion units in 2025 (-10.0%)

98%
Source evidence
“Total smokeable products segment’s cigarettes shipment volume in the United States was 61.8 billion units in 2025, a decrease of 10.0% from 2024.”

Oral tobacco products (USSTC/Helix)

MST (Copenhagen, Skoal, Red Seal) plus on! nicotine pouches; 732.4 million units in 2025 (-5.5%)

98%
Source evidence
“Total oral tobacco products segment’s shipment volume was 732.4 million units in 2025, a decrease of 5.5% from 2024.”

E-vapor products (NJOY)

NJOY ACE covered by FDA MGOs but subject to ITC import ban

97%
Source evidence
“NJOY ACE, the principal e-vapor product of NJOY, is subject to an exclusion order and cease-and-desist orders issued by the U.S. International Trade Commission (“ITC”) prohibiting the importation and sale of NJOY ACE in the United States”

Horizon heated tobacco joint venture

Horizon JV (75%/25% with JTIUH) for U.S. HTS commercialization; no products in market yet; PM USA to make Marlboro HTS consumables

95%
Source evidence
“At December 31, 2025, we owned a 75% economic interest in Horizon Innovations LLC (“Horizon”), a joint venture with JTI (US) Holding, Inc. (“JTIUH”)”

Machine-made large cigars (Middleton)

Middleton cigars ~1.8 billion units in 2025 (+1.8%); Black & Mild principal brand; third-party importer supplies

95%
Source evidence
“Total smokeable products segment’s cigars shipment volume was approximately 1.8 billion units in 2025, an increase of 1.8% from 2024.”

Oral tobacco products segment revenues 2025 vs 2024

Net revenues $2,802M (+0.9%); adjusted OCI $1,835M (+1.3%) with 67.9% margin; reported OCI up 26.2% on lapping 2024 Skoal impairment

99%
Source evidence
“Net revenues$2,802 $2,776 Excise taxes(98)(105) Revenues net of excise taxes$2,704 $2,671”

Operations and dependencies

Tobacco leaf sourcing

Contract growing programs for PM USA and USSTC; leaf merchants for Middleton; nicotine materials from suppliers for Helix/NJOY

95%
Source evidence
“PM USA purchases the majority of its burley and flue-cured leaf tobaccos directly from domestic tobacco growers.”

Positioning and strategy

Nicotine pouch category shift eroding MST

US nicotine pouch category grew to 53.3% of oral tobacco (+10.0 pts); on! pouch share 15.4% (-3.4 pts); total category volume +14%

98%
Source evidence
“The U.S. nicotine pouch category grew to 53.3% of the U.S. oral tobacco category, an increase of 10.0 share points. In addition, on!'s share of the nicotine pouch category was 15.4%, a decrease of 3.4 share points.”

Long-term growth priorities

International competition in top oral tobacco markets, pathway into heated tobacco and e-vapor, and entering non-nicotine categories with broad commercial distribution

90%
Source evidence
“Compete internationally in the top innovative oral tobacco markets and develop a pathway to participate in heated tobacco and e-vapor markets; and Enter non-nicotine categories with broad commercial distribution of at least fiv”

Risks, financing, and outlook

Total long-term debt and weighted-average coupon

Total long-term debt $25.7B at Dec 31, 2025 ($24.9B in 2024), all fixed-rate, weighted-average coupon ~4.5%

99%
Source evidence
“At December 31, 2025 and 2024, our total long-term debt was $25.7 billion and $24.9 billion, respectively.”

2025 debt issuance and repayment activity

Issued $2.0B notes in 2025; repaid $750M notes and €750M ($857M) Euro notes at maturity; repaid ~$1.1B notes in Feb 2026

98%
Source evidence
“In the first and third quarters of 2025, we issued U.S. dollar denominated senior unsecured notes each in the aggregate principal amount of $1.0 billion ($2.0 billion total).”

Credit ratings and recent rating actions

Moody's A3/P-2 Stable; S&P BBB+/A-2 Stable (upgraded May 2025); Fitch BBB/F2 Stable (upgraded Feb 13, 2026)

98%
Source evidence
“On February 13, 2026, Fitch changed its short-term debt credit rating to F1 from F2 and long-term debt credit rating to BBB+ from BBB.”

on! PLUS commercialization

on! PLUS launched Q1 2026; additional on! and NJOY products planned

90%
Source evidence
“in the first quarter of 2026, we commercialized on! PLUS oral nicotine pouch products, and we have plans to commercialize additional on! and NJOY products.”

FDA regulatory actions and PMTA review risk

FDA actions/inaction can restrict products (including on! pouches pending PMTA), and protracted PMTA reviews create competitive disadvantage

95%
Source evidence
“A protracted FDA review of one of our operating companies’ PMTAs would allow competitive products already on the market to establish market share”

Competition from innovative and illicit nicotine products

Innovative and illicit e-vapor/nicotine pouch growth erodes cigarette and MST industry volumes

95%
Source evidence
“the proliferation of illicit flavored disposable e-vapor products has negatively impacted the growth of FDA-authorized e-vapor products, including NJOY’s products.”

Illicit e-vapor market disruption and reassessed smoke-free goals

Smoke-free goals under reassessment due to illicit e-vapor products that evaded the regulatory process

95%
Source evidence
“Due to ongoing market disruption caused by illicit e-vapor products that have evaded the regulatory process, we continue to reassess our smoke-free goals”

Macroeconomic down-trading risk

Inflation-driven down-trading to discount brands pressures premium volumes and pricing power

95%
Source evidence
“In periods of economic uncertainty and high inflation, we have observed that adult nicotine consumers reduce consumption, purchase more discount brands and consider lower-priced nicotine products”

Declining cigarette industry volume

Governmental/private actions and diminishing social acceptance of smoking have reduced cigarette industry volume and are expected to continue to reduce consumption

94%
Source evidence
“These actions, combined with the diminishing social acceptance of smoking, have resulted in reduced cigarette industry volume, and we expect that these factors will continue to reduce cigarette consumption levels”

Litigation settlement cost disadvantage

Non-settling discount manufacturers have cost advantages; PM USA settlement payments drove substantial cigarette price increases

90%
Source evidence
“PM USA faces competition from lower-priced brands sold by certain domestic and foreign manufacturers that have cost advantages because they are not parties to settlements of certain healthcare cost recovery litigation”

Climate/environmental regulatory requirements

Climate change and environmental sustainability legal/regulatory requirements may increase compliance and manufacturing costs

90%
Source evidence
“New or additional requirements may relate to, among other things, greenhouse gas emissions, alternative energy policy, single-use plastics, the disposal of nicotine products”

Material exposure graph

United States
Revenue Exposure

Altria operates primarily within the U.S. and generates substantially all revenue from domestic customers; products are manufactured and sold domestically.

Relevance 95·Dependency 95·Confidence 98
Source evidence
“We operate primarily within the United States and generate substantially all of our revenue from domestic customers.”
FDA premarket tobacco application (PMTA) review
Regulatory Exposure

FDA authorization and review speed determine whether Altria's smoke-free products (NJOY, on!) can be marketed; protracted reviews favor competitors.

Relevance 95·Dependency 85·Confidence 95
Source evidence
“We cannot predict whether regulators, including the FDA, will permit the marketing or sale of any particular innovative products”
oral nicotine pouches
Demand Driver

Growth of oral nicotine pouches is driving total oral tobacco category growth while eroding MST volumes and Altria's total oral tobacco retail share.

Relevance 92·Dependency 70·Confidence 97
Source evidence
“Total oral tobacco products category industry volume increased by an estimated 14% over the six months ended December 31, 2025, driven primarily by growth in oral nicotine pouches, partially offset by declines in MST volumes.”
Nicotine product excise taxes
Tax Exposure

Excise tax increases at federal, state, and local levels reduce consumption and shift purchases to discount and contraband products, hurting premium volumes.

Relevance 90·Dependency 80·Confidence 93
Source evidence
“Significant increases in taxes or fees on nicotine products (including traditional tobacco products as well as e-vapor and oral nicotine products) have been proposed or enacted”
tobacco litigation
Legal Exposure

Tobacco-related litigation (RICO, Engle-type Florida cases, NJOY patent cases) creates potential for significant damages, non-monetary remedies, and bonding risk.

Relevance 90·Dependency 70·Confidence 92
Source evidence
“Damages claimed in some tobacco-related or other litigation are significant and, in certain cases, have ranged in the billions of dollars.”
moist smokeless tobacco (MST)
Revenue Exposure

MST retail share losses drove a 5.5% domestic shipment volume decline; higher pricing ($263M) mostly offset volume/mix losses ($237M) in segment revenue.

Relevance 88·Dependency 80·Confidence 96
Source evidence
“Our oral tobacco products segment's reported domestic shipment volume decreased 5.5%, driven primarily by retail share losses, calendar differences and other factors”
illicit e-vapor market
Demand Driver

Illicit e-vapor products evading FDA regulation disrupt the legitimate e-vapor market and caused Altria to reassess its 2028 smoke-free goals.

Relevance 88·Dependency 75·Confidence 94
Source evidence
“Due to ongoing market disruption caused by illicit e-vapor products that have evaded the regulatory process, we continue to reassess our smoke-free goals”
E-vapor products
Demand Driver

Growth of legal and illicit e-vapor products (especially illicit flavored disposables) reduces cigarette and MST consumption and undermines NJOY's FDA-authorized products.

Relevance 85·Dependency 75·Confidence 90
Source evidence
“The growth of innovative nicotine products, including legal and illicit e-vapor products and oral nicotine pouches, has contributed to reductions in the consumption levels and industry sales volumes of cigarettes and other tobacco products”
Inflation
Demand Driver

Inflation and economic uncertainty cause adult nicotine consumers to cut consumption and down-trade to discount brands, pressuring premium brand volumes and pricing.

Relevance 85·Dependency 70·Confidence 90
Source evidence
“The willingness of adult nicotine consumers to purchase premium brands is affected by macroeconomic conditions, including inflation and overall economic stability.”
NJOY e-vapor products
Competitive Exposure

NJOY ACE importation ban and NJOY Daily patent litigation could materially affect e-vapor goodwill valuation and category plans.

Relevance 85·Dependency 70·Confidence 90
Source evidence
“If the bans with respect to NJOY ACE remain effective or we experience unfavorable outcomes with respect to the patent litigation relating to NJOY Daily”
on! oral nicotine pouches
Revenue Exposure

on! shipment volume grew to 177.8M cans, but on!'s share of the fast-growing nicotine pouch category fell 3.4 points to 15.4%, indicating competitive pressure within the key growth category.

Relevance 85·Dependency 60·Confidence 95
Source evidence
“on!'s share of the nicotine pouch category was 15.4%, a decrease of 3.4 share points.”
ITC exclusion order on NJOY ACE
Legal Exposure

ITC exclusion and cease-and-desist orders prohibit importation and sale of NJOY ACE, Altria's principal e-vapor product, blocking a key innovative growth avenue pending appeal.

Relevance 80·Dependency 70·Confidence 90
Source evidence
“the ITC imposed bans on the importation of NJOY ACE into the United States and our sale and marketing of NJOY ACE products previously imported into the United States.”
FDA PMTA review
Regulatory Exposure

Lengthy, unpredictable FDA PMTA review periods complicate new-product commercialization planning for smoke-free nicotine products.

Relevance 75·Dependency 65·Confidence 90
Source evidence
“Lengthy and unpredictable regulatory review periods complicate efforts to strategize and plan with respect to commercialization of new products”
Wholesalers and large retail organizations
Customer Exposure

Tobacco products are sold principally to wholesalers/distributors and large retail chain organizations in the U.S.

Relevance 70·Dependency 80·Confidence 90
Source evidence
“Our tobacco subsidiaries sell their tobacco products principally to wholesalers (including distributors) and large retail organizations, including chain stores.”
Tobacco leaf
Raw Material Dependency

PM USA and USSTC rely on domestic contract growing programs and leaf merchants for burley, flue-cured and dark tobaccos; Middleton buys via leaf merchants.

Relevance 70·Dependency 75·Confidence 90
Source evidence
“In the United States, under a contract growing program, PM USA purchases the majority of its burley and flue-cured leaf tobaccos directly from domestic tobacco growers.”
Anheuser-Busch InBev (ABI)
Revenue Exposure

Altria holds an equity investment in ABI, the world's largest brewer, contributing to earnings via equity method investment income.

Relevance 70·Dependency 55·Confidence 90
Source evidence
“Our investments in equity securities include ABI, the world’s largest brewer, and Cronos, a leading Canadian cannabinoid company.”
Anheuser-Busch InBev SA/NV
Tax Exposure

The ABI equity stake drives both dividend income ($208M in 2025) and a $303M unrecognized tax benefit from the change in foreign attribution rules.

Relevance 60·Dependency 55·Confidence 90
Source evidence
“Substantially all of the 2025 amount relates to unrecognized tax benefits from the change in the application of foreign attribution rules relevant to our investment in ABI.”
climate change regulation
Cost Driver

New climate/environmental regulations (GHG emissions, plastics, product disposal) could increase compliance and manufacturing costs.

Relevance 60·Dependency 50·Confidence 88
Source evidence
“These additional laws and regulations could materially adversely affect our business, results of operations, cash flows and financial condition by increasing our compliance and manufacturing costs”
Full company information
Latest profile, trading, valuation, and identifier data stored for MO.
Share price
$78.08
Market cap
$129.86B
Exchange
NYSE
Currency
USD
CEO
Salvatore Mancuso
Employees
5,900
IPO date
01/07/1985
Beta
0.463
Last dividend
$0.00
Day range
$77.13 – $78.57
52-week range
$54.70 – $79.81
1-day performance
1.48%
1-year performance
42.74%
Current drawdown (1Y)
-2.17%
CIK
0000764180
CUSIP
02209S103
ISIN
US02209S1033
Created
07/12/2025, 05:18:05
Last update
04/11/2026, 18:29:18

Track Altria Group, Inc. with an AI analyst

See which prediction-market events move MO, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to MO from your Railway `news_articles` table.

Up 33% From Its 52-Week Low: 1 Glaring Red Flag That Makes Altria Stock a Dangerous Buy at $73

24/7 Wall Street • STOCK • 12/06/2026, 10:47:41

Earn $5,000+ Yearly With These 4 Dividend Stocks

24/7 Wall Street • STOCK • 09/06/2026, 16:53:46

Altria (MO) Just Overtook the 20-Day Moving Average

Zacks Investment Research • STOCK • 08/06/2026, 12:35:15

Altria (MO) Gains As Market Dips: What You Should Know

Zacks Investment Research • STOCK • 05/06/2026, 20:46:20

Altria Group, Inc. (MO) is Attracting Investor Attention: Here is What You Should Know

Zacks Investment Research • STOCK • 03/06/2026, 12:00:39

Altria: I See A Path Toward A $100 Share Price Within 5 Years

Seeking Alpha • STOCK • 29/05/2026, 18:51:20

Altria (MO) Upgraded to Buy: What Does It Mean for the Stock?

Zacks Investment Research • STOCK • 25/05/2026, 15:01:19

Is Altria Group (MO) Outperforming Other Consumer Staples Stocks This Year?

Zacks Investment Research • STOCK • 25/05/2026, 12:41:31

Altria Just Posted Its Strongest Growth in Years, but There's a Catch

The Motley Fool • STOCK • 23/05/2026, 14:00:00

Altria Group, Inc. (MO) is Attracting Investor Attention: Here is What You Should Know

Zacks Investment Research • STOCK • 20/05/2026, 12:01:22

Altria: Diversified Tobacco With Rich Return Prospects - Reiterate Buy

Seeking Alpha • STOCK • 16/05/2026, 17:00:00

Altria Holds 2026 Annual Meeting of Shareholders; Declares Regular Quarterly Dividend of $1.06 Per Share

Business Wire • STOCK • 14/05/2026, 16:30:00